XYNTHA SOLOFUSE

Pfizer Canada Ulc🇨🇦 Health Canada

Approval Id: 0dd6deda1c6cddbd
Drug Approval Canada Name: XYNTHA SOLOFUSE
Product Name: XYNTHA SOLOFUSE
Status: Marketed
Status Date: 2019-09-27
Original Market Date: 2019-09-27
Din: 02374064
Drug Class: Human
Dosage Form: Powder For Solution
Route Of Administration: Intravenous
Schedule: Schedule D
Ahfs: 20:28.16
Atc Original: B02BD02 COAGULATION FACTOR VIII
Atc Name: b 02 bd 02
Aig Number: 0147521002
Company Name: Pfizer Canada Ulc
Company Address: 17300 Trans-Canada Highway, Kirkland, Quebec, Canada, H9J 2M5
Company Detail Path: /organization/pfizer-canada-ulc

MOROCTOCOG ALFA

500 UNIT / SYR

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

0dd6deda1c6cddbd

Type

Standard